Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 8 |
NetGPI | no | yes: 0, no: 8 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 5 |
GO:0110165 | cellular anatomical entity | 1 | 5 |
Related structures:
AlphaFold database: Q4Q8U5
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_MEL_PAP_1 | 428 | 434 | PF00089 | 0.500 |
CLV_NRD_NRD_1 | 16 | 18 | PF00675 | 0.466 |
CLV_NRD_NRD_1 | 217 | 219 | PF00675 | 0.682 |
CLV_NRD_NRD_1 | 270 | 272 | PF00675 | 0.590 |
CLV_NRD_NRD_1 | 291 | 293 | PF00675 | 0.734 |
CLV_NRD_NRD_1 | 389 | 391 | PF00675 | 0.629 |
CLV_NRD_NRD_1 | 46 | 48 | PF00675 | 0.595 |
CLV_NRD_NRD_1 | 5 | 7 | PF00675 | 0.505 |
CLV_PCSK_FUR_1 | 14 | 18 | PF00082 | 0.463 |
CLV_PCSK_KEX2_1 | 16 | 18 | PF00082 | 0.466 |
CLV_PCSK_KEX2_1 | 179 | 181 | PF00082 | 0.669 |
CLV_PCSK_KEX2_1 | 217 | 219 | PF00082 | 0.635 |
CLV_PCSK_KEX2_1 | 291 | 293 | PF00082 | 0.730 |
CLV_PCSK_KEX2_1 | 46 | 48 | PF00082 | 0.591 |
CLV_PCSK_KEX2_1 | 5 | 7 | PF00082 | 0.505 |
CLV_PCSK_PC1ET2_1 | 179 | 181 | PF00082 | 0.650 |
CLV_PCSK_PC7_1 | 175 | 181 | PF00082 | 0.613 |
CLV_PCSK_SKI1_1 | 227 | 231 | PF00082 | 0.643 |
CLV_PCSK_SKI1_1 | 334 | 338 | PF00082 | 0.629 |
CLV_PCSK_SKI1_1 | 6 | 10 | PF00082 | 0.517 |
DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.652 |
DEG_SPOP_SBC_1 | 22 | 26 | PF00917 | 0.763 |
DOC_CKS1_1 | 326 | 331 | PF01111 | 0.483 |
DOC_CYCLIN_RxL_1 | 331 | 340 | PF00134 | 0.428 |
DOC_MAPK_FxFP_2 | 163 | 166 | PF00069 | 0.490 |
DOC_MAPK_gen_1 | 14 | 22 | PF00069 | 0.718 |
DOC_MAPK_gen_1 | 179 | 185 | PF00069 | 0.435 |
DOC_MAPK_gen_1 | 261 | 269 | PF00069 | 0.535 |
DOC_MAPK_gen_1 | 429 | 438 | PF00069 | 0.316 |
DOC_MAPK_gen_1 | 5 | 13 | PF00069 | 0.687 |
DOC_MAPK_MEF2A_6 | 120 | 129 | PF00069 | 0.542 |
DOC_MAPK_MEF2A_6 | 5 | 13 | PF00069 | 0.633 |
DOC_MAPK_NFAT4_5 | 6 | 14 | PF00069 | 0.571 |
DOC_PP4_FxxP_1 | 163 | 166 | PF00568 | 0.490 |
DOC_PP4_FxxP_1 | 207 | 210 | PF00568 | 0.450 |
DOC_USP7_MATH_1 | 312 | 316 | PF00917 | 0.524 |
DOC_USP7_MATH_1 | 36 | 40 | PF00917 | 0.704 |
DOC_USP7_MATH_1 | 384 | 388 | PF00917 | 0.365 |
DOC_USP7_MATH_1 | 55 | 59 | PF00917 | 0.769 |
DOC_WW_Pin1_4 | 152 | 157 | PF00397 | 0.514 |
DOC_WW_Pin1_4 | 325 | 330 | PF00397 | 0.590 |
DOC_WW_Pin1_4 | 39 | 44 | PF00397 | 0.760 |
DOC_WW_Pin1_4 | 84 | 89 | PF00397 | 0.702 |
LIG_14-3-3_CanoR_1 | 108 | 116 | PF00244 | 0.724 |
LIG_14-3-3_CanoR_1 | 14 | 22 | PF00244 | 0.691 |
LIG_14-3-3_CanoR_1 | 158 | 162 | PF00244 | 0.481 |
LIG_14-3-3_CanoR_1 | 175 | 183 | PF00244 | 0.350 |
LIG_14-3-3_CanoR_1 | 264 | 268 | PF00244 | 0.542 |
LIG_14-3-3_CanoR_1 | 299 | 309 | PF00244 | 0.533 |
LIG_14-3-3_CanoR_1 | 338 | 342 | PF00244 | 0.404 |
LIG_Actin_WH2_2 | 376 | 392 | PF00022 | 0.449 |
LIG_ActinCP_TwfCPI_2 | 207 | 217 | PF01115 | 0.413 |
LIG_BRCT_BRCA1_1 | 159 | 163 | PF00533 | 0.530 |
LIG_BRCT_BRCA1_1 | 265 | 269 | PF00533 | 0.541 |
LIG_Clathr_ClatBox_1 | 238 | 242 | PF01394 | 0.464 |
LIG_FHA_1 | 124 | 130 | PF00498 | 0.399 |
LIG_FHA_1 | 145 | 151 | PF00498 | 0.411 |
LIG_FHA_1 | 16 | 22 | PF00498 | 0.594 |
LIG_FHA_1 | 180 | 186 | PF00498 | 0.492 |
LIG_FHA_1 | 233 | 239 | PF00498 | 0.423 |
LIG_FHA_1 | 331 | 337 | PF00498 | 0.477 |
LIG_FHA_1 | 409 | 415 | PF00498 | 0.422 |
LIG_FHA_2 | 319 | 325 | PF00498 | 0.547 |
LIG_LIR_Apic_2 | 160 | 166 | PF02991 | 0.506 |
LIG_LIR_Gen_1 | 356 | 366 | PF02991 | 0.453 |
LIG_LIR_Gen_1 | 422 | 432 | PF02991 | 0.401 |
LIG_LIR_Nem_3 | 160 | 165 | PF02991 | 0.394 |
LIG_LIR_Nem_3 | 356 | 361 | PF02991 | 0.439 |
LIG_LIR_Nem_3 | 422 | 428 | PF02991 | 0.393 |
LIG_LYPXL_yS_3 | 103 | 106 | PF13949 | 0.649 |
LIG_MLH1_MIPbox_1 | 159 | 163 | PF16413 | 0.530 |
LIG_PCNA_yPIPBox_3 | 217 | 229 | PF02747 | 0.438 |
LIG_PTAP_UEV_1 | 328 | 333 | PF05743 | 0.367 |
LIG_SH2_CRK | 375 | 379 | PF00017 | 0.399 |
LIG_SH2_SRC | 375 | 378 | PF00017 | 0.371 |
LIG_SH2_STAP1 | 318 | 322 | PF00017 | 0.519 |
LIG_SH2_STAP1 | 358 | 362 | PF00017 | 0.364 |
LIG_SH2_STAP1 | 375 | 379 | PF00017 | 0.353 |
LIG_SH2_STAP1 | 393 | 397 | PF00017 | 0.298 |
LIG_SH2_STAP1 | 439 | 443 | PF00017 | 0.417 |
LIG_SH2_STAT3 | 393 | 396 | PF00017 | 0.298 |
LIG_SH2_STAT5 | 128 | 131 | PF00017 | 0.448 |
LIG_SH2_STAT5 | 138 | 141 | PF00017 | 0.318 |
LIG_SH2_STAT5 | 142 | 145 | PF00017 | 0.374 |
LIG_SH2_STAT5 | 148 | 151 | PF00017 | 0.226 |
LIG_SH2_STAT5 | 231 | 234 | PF00017 | 0.362 |
LIG_SH2_STAT5 | 377 | 380 | PF00017 | 0.397 |
LIG_SH2_STAT5 | 441 | 444 | PF00017 | 0.446 |
LIG_SH3_2 | 329 | 334 | PF14604 | 0.518 |
LIG_SH3_3 | 323 | 329 | PF00018 | 0.567 |
LIG_SUMO_SIM_anti_2 | 182 | 187 | PF11976 | 0.518 |
LIG_SUMO_SIM_par_1 | 235 | 242 | PF11976 | 0.390 |
LIG_TRAF2_1 | 88 | 91 | PF00917 | 0.778 |
MOD_CDC14_SPxK_1 | 155 | 158 | PF00782 | 0.526 |
MOD_CDK_SPxK_1 | 152 | 158 | PF00069 | 0.518 |
MOD_CDK_SPxxK_3 | 39 | 46 | PF00069 | 0.729 |
MOD_CK1_1 | 237 | 243 | PF00069 | 0.461 |
MOD_CK1_1 | 25 | 31 | PF00069 | 0.703 |
MOD_CK1_1 | 263 | 269 | PF00069 | 0.507 |
MOD_CK1_1 | 285 | 291 | PF00069 | 0.564 |
MOD_CK1_1 | 313 | 319 | PF00069 | 0.548 |
MOD_CK1_1 | 38 | 44 | PF00069 | 0.669 |
MOD_CK1_1 | 84 | 90 | PF00069 | 0.664 |
MOD_CK2_1 | 318 | 324 | PF00069 | 0.574 |
MOD_CK2_1 | 353 | 359 | PF00069 | 0.413 |
MOD_CMANNOS | 293 | 296 | PF00535 | 0.729 |
MOD_GlcNHglycan | 111 | 114 | PF01048 | 0.555 |
MOD_GlcNHglycan | 27 | 30 | PF01048 | 0.487 |
MOD_GlcNHglycan | 310 | 313 | PF01048 | 0.701 |
MOD_GlcNHglycan | 315 | 318 | PF01048 | 0.702 |
MOD_GlcNHglycan | 38 | 41 | PF01048 | 0.499 |
MOD_GlcNHglycan | 386 | 389 | PF01048 | 0.704 |
MOD_GlcNHglycan | 403 | 406 | PF01048 | 0.540 |
MOD_GlcNHglycan | 50 | 53 | PF01048 | 0.610 |
MOD_GlcNHglycan | 70 | 73 | PF01048 | 0.540 |
MOD_GSK3_1 | 144 | 151 | PF00069 | 0.372 |
MOD_GSK3_1 | 21 | 28 | PF00069 | 0.752 |
MOD_GSK3_1 | 282 | 289 | PF00069 | 0.540 |
MOD_GSK3_1 | 308 | 315 | PF00069 | 0.524 |
MOD_GSK3_1 | 35 | 42 | PF00069 | 0.651 |
MOD_N-GLC_1 | 152 | 157 | PF02516 | 0.714 |
MOD_NEK2_1 | 109 | 114 | PF00069 | 0.721 |
MOD_NEK2_1 | 130 | 135 | PF00069 | 0.367 |
MOD_NEK2_1 | 21 | 26 | PF00069 | 0.781 |
MOD_NEK2_1 | 310 | 315 | PF00069 | 0.502 |
MOD_NEK2_1 | 336 | 341 | PF00069 | 0.385 |
MOD_NEK2_1 | 343 | 348 | PF00069 | 0.435 |
MOD_NEK2_1 | 383 | 388 | PF00069 | 0.450 |
MOD_NEK2_2 | 123 | 128 | PF00069 | 0.447 |
MOD_NEK2_2 | 157 | 162 | PF00069 | 0.452 |
MOD_PIKK_1 | 286 | 292 | PF00454 | 0.584 |
MOD_PKA_1 | 179 | 185 | PF00069 | 0.516 |
MOD_PKA_2 | 109 | 115 | PF00069 | 0.666 |
MOD_PKA_2 | 15 | 21 | PF00069 | 0.725 |
MOD_PKA_2 | 157 | 163 | PF00069 | 0.498 |
MOD_PKA_2 | 174 | 180 | PF00069 | 0.342 |
MOD_PKA_2 | 263 | 269 | PF00069 | 0.561 |
MOD_PKA_2 | 282 | 288 | PF00069 | 0.361 |
MOD_PKA_2 | 337 | 343 | PF00069 | 0.431 |
MOD_Plk_4 | 123 | 129 | PF00069 | 0.485 |
MOD_Plk_4 | 144 | 150 | PF00069 | 0.392 |
MOD_Plk_4 | 157 | 163 | PF00069 | 0.461 |
MOD_Plk_4 | 234 | 240 | PF00069 | 0.351 |
MOD_ProDKin_1 | 152 | 158 | PF00069 | 0.518 |
MOD_ProDKin_1 | 325 | 331 | PF00069 | 0.581 |
MOD_ProDKin_1 | 39 | 45 | PF00069 | 0.761 |
MOD_ProDKin_1 | 84 | 90 | PF00069 | 0.702 |
TRG_DiLeu_BaLyEn_6 | 101 | 106 | PF01217 | 0.601 |
TRG_ENDOCYTIC_2 | 103 | 106 | PF00928 | 0.655 |
TRG_ENDOCYTIC_2 | 250 | 253 | PF00928 | 0.439 |
TRG_ENDOCYTIC_2 | 358 | 361 | PF00928 | 0.471 |
TRG_ENDOCYTIC_2 | 375 | 378 | PF00928 | 0.308 |
TRG_ER_diArg_1 | 13 | 16 | PF00400 | 0.660 |
TRG_ER_diArg_1 | 217 | 219 | PF00400 | 0.482 |
TRG_ER_diArg_1 | 291 | 293 | PF00400 | 0.534 |
TRG_ER_diArg_1 | 341 | 344 | PF00400 | 0.394 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1ILV3 | Leptomonas seymouri | 49% | 100% |
A0A1X0P8N3 | Trypanosomatidae | 24% | 100% |
A0A3S7X083 | Leishmania donovani | 84% | 100% |
A4HF91 | Leishmania braziliensis | 66% | 82% |
A4I2H3 | Leishmania infantum | 84% | 100% |
C9ZX21 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 27% | 100% |
E9AYM7 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 80% | 100% |